Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.

Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine, Johns Hopkins Medicine, Children’s Hospital of Philadelphia, and the University of Pittsburgh in collaboration with other institutions.

The Transcatheter Cardiovascular Therapeutics (TCT) conference has long been one of the top educational forums in interventional cardiovascular medicine.

Dr. Chani Traube, the Gerald M. Loughlin, MD Professor of Pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant, with the possibility of extending to a total of $17 million over five years, from the National Institutes of Health, for a large-scale clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation (OPTICOM).

Early results from 4,000 babies in the GUARDIAN study show that genome sequencing picks up many more serious health conditions than standard newborn screening and is favored by most parents.

NewYork-Presbyterian announced the launch today of one of the most ambitious initiatives in its 250-year history: the $2 billion For Every Future campaign.

Dr. Uma M. Reddy, professor and vice chair of research in the Department of Obstetrics & Gynecology at Columbia University Vagelos College of Physicians and Surgeons and professor of population & family health in the Mailman School of Public Health, is among a select group of leaders in medicine and health elected this year to the National Academy of Medicine.

NewYork-Presbyterian Hospital has been recognized as the #1 children’s hospital in New York, according to U.S. News & World Report’s 2024-2025 “Best Children’s Hospitals” rankings. This is the 18th year in a row that the Hospital has ranked among the best children’s hospitals in the nation.